Soraphen A, another ACC1 inhibitor, can pharmacologically inhibit fatty acid synthesis in diet-induced obesity mice and significantly suppress weight gain, which sheds new light on controlling diet-induced obesity (26). The gene discussed is ACACA; the disease is obesity due to melanocortin 4 receptor deficiency.